Summary statistics and unadjusted and adjusted treatment effects
| 4-month scores | Control (n=13) | My Journey 3 (n=20) | Unadjusted analysis | Analysis adjusted for baseline score | ||
| Mean (SD) | Mean (SD) | Estimated difference | 95% CI | Estimated difference | 95% CI | |
| SIX (Social Outcomes) | 3.3 (1.9) | 3.6 (1.3) | 0.29 | −0.84 to 1.43 | 0.16 | −0.6 to 0.92 |
| MHCS (Mental Health Confidence) | 66.4 (12.7) | 63 (15.8) | −3.43 | −14.1 to 7.25 | −4.81 | −14.88 to 5.25 |
| QPR (Recovery) | ||||||
| Intrapersonal | 47.8 (10.6) | 43.2 (12.2) | −4.57 | −13 to 3.87 | −2.01 | −8.43 to 4.49 |
| Interpersonal | 13.9 (2.4) | 13.2 (2.3) | −0.72 | −2.39 to 0.95 | −0.42 | −1.97 to 1.13 |
| MHCS (Mental Health Confidence) | 46.1 (9.9) | 44 (11.3) | −2.08 | −9.9 to 5.74 | −0.19 | −7.28 to 6.9 |
| DIALOG | ||||||
| Quality of life | 4.4 (1.2) | 4.5 (0.6) | 0.07 | −0.58 to 0.71 | 0.18 | −0.38 to 0.74 |
| Treatment satisfaction | 5.4 (0.7) | 5 (0.5) | −0.38 | −0.83 to 0.06 | −0.17 | −0.6 to 0.25 |
| PANSS (Symptom Severity) | ||||||
| Positive | 9.3 (2.9) | 11.4 (5.1) | 2.09 | −1.24 to 5.4 | 1.9 | −0.49 to 4.3 |
| Negative | 10 (2.3) | 11.1 (3.9) | 1.05 | −1.51 to 3.62 | 0.54 | −1.6 to 2.67 |
| General | 23 (4) | 24 (6.7) | 1.21 | −3.19 to 5.61 | 1.35 | −2.68 to 5.37 |
| 12-month scores | Control (n=14) | My Journey 3 (n=16) | Unadjusted analysis | Analysis adjusted for baseline score | ||
| Mean (SD) | Mean (SD) | Estimated difference | 95% CI | Estimated difference | 95% CI | |
| SIX (Social Outcomes) | 3.2 (1.9) | 3.5 (1.5) | 0.29 | −0.97 to 1.54 | 0.29 | −0.73 to 1.3 |
| MHCS (Mental Health Confidence) | 66.2 (14.1) | 71.1 (12.1) | 4.81 | −5 to 14.62 | 3.03 | −6.04 to 12.1 |
| QPR (Recovery) | ||||||
| Intrapersonal | 47.3 (11.5) | 49.5 (11.1) | 2.2 | −6.25 to 10.7 | 3.21 | −4.12 to 10.5 |
| Interpersonal | 13.6 (3.4) | 15.1 (3.3) | 1.44 | −1.09 to 3.96 | 1.62 | −0.89 to 4.12 |
| MHCS (Mental Health Confidence) | 45.6 (11.3) | 49.3 (9.7) | 3.61 | −4.24 to 11.46 | 5.03 | −1.67 to 11.7 |
| DIALOG | ||||||
| Quality of life | 4.7 (0.9) | 5 (0.7) | 0.28 | −0.31 to 0.87 | 0.24 | −0.33 to 0.81 |
| Treatment satisfaction | 5.3 (1) | 5.2 (1.2) | −0.12 | −0.93 to 0.69 | 0.31 | −0.42 to 1.04 |
| PANSS (Symptom Severity) | ||||||
| Positive | 9.5 (2.1) | 10.2 (2.1) | 0.69 | −0.98 to 2.36 | 0.88 | −0.62 to 2.38 |
| Negative | 10.2 (2.2) | 10.9 (3.3) | 0.77 | −1.51 to 3.05 | 0.14 | −1.56 to 1.84 |
| General | 23.5 (5.4) | 22.1 (3.5) | −1.38 | −4.82 to 2.07 | −1 | −4.57 to 2.55 |
| SES (Engagement with Services) | 10 (6.2) | 9.5 (8) | −0.4 | −6.08 to 5.28 | 3.11 | −1.57 to 7.79 |
Estimated differences and associated 95% Confidence Intervals from linear regression models with thecontrol group as reference. Missing data: 4-month PANSS scores – one control group participant, one treatment group participant. 12-month PANSS scores – two control group participants. Note: 12-month SES data available for 13 control group participants, and 14 treatment group participants.